Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 183

1.

N-Docosahexaenoylethanolamine (synaptamide): Carbon-14 radiolabeling and metabolic studies.

Sonti S, Duclos RI Jr, Tolia M, Gatley SJ.

Chem Phys Lipids. 2018 Jan;210:90-97. doi: 10.1016/j.chemphyslip.2017.11.002. Epub 2017 Nov 8.

PMID:
29126855
2.

Brain uptake and metabolism of the endocannabinoid anandamide labeled in either the arachidonoyl or ethanolamine moiety.

Hu K, Sonti S, Glaser ST, Duclos RI Jr, Gatley SJ.

Nucl Med Biol. 2017 Feb;45:43-50. doi: 10.1016/j.nucmedbio.2016.11.001. Epub 2016 Nov 9.

PMID:
27889577
3.

Tolerance to the Diuretic Effects of Cannabinoids and Cross-Tolerance to a κ-Opioid Agonist in THC-Treated Mice.

Chopda GR, Parge V, Thakur GA, Gatley SJ, Makriyannis A, Paronis CA.

J Pharmacol Exp Ther. 2016 Aug;358(2):334-41. doi: 10.1124/jpet.116.232132. Epub 2016 May 26.

4.

Integrity of (111)In-radiolabeled superparamagnetic iron oxide nanoparticles in the mouse.

Wang H, Kumar R, Nagesha D, Duclos RI Jr, Sridhar S, Gatley SJ.

Nucl Med Biol. 2015 Jan;42(1):65-70. doi: 10.1016/j.nucmedbio.2014.08.014. Epub 2014 Sep 6.

PMID:
25277378
5.

Synthesis and preliminary evaluation of N-(16-18F-fluorohexadecanoyl)ethanolamine (18F-FHEA) as a PET probe of N-acylethanolamine metabolism in mouse brain.

Pandey MK, DeGrado TR, Qian K, Jacobson MS, Hagen CE, Duclos RI Jr, Gatley SJ.

ACS Chem Neurosci. 2014 Sep 17;5(9):793-802. doi: 10.1021/cn400214j. Epub 2014 Jul 16.

PMID:
25003845
6.

Assay and inhibition of diacylglycerol lipase activity.

Johnston M, Bhatt SR, Sikka S, Mercier RW, West JM, Makriyannis A, Gatley SJ, Duclos RI Jr.

Bioorg Med Chem Lett. 2012 Jul 15;22(14):4585-92. doi: 10.1016/j.bmcl.2012.05.101. Epub 2012 Jun 6.

7.

A methodology for radiolabeling of the endocannabinoid 2-arachidonoylglycerol (2-AG).

Duclos RI Jr, Johnston M, Vadivel SK, Makriyannis A, Glaser ST, Gatley SJ.

J Org Chem. 2011 Apr 1;76(7):2049-55. doi: 10.1021/jo102277q. Epub 2011 Mar 3.

8.

The preparation of 2-O-[1'-C]arachidonoyl-1-O-stearoyl-sn-glycerol.

Duclos RI, Gatley SJ, Bhatt SR, Johnston M.

J Labelled Comp Radiopharm. 2009 Jun 1;52(8):324-326.

9.

Long-term effects of irradiation with iron-56 particles on the nigrostriatal dopamine system.

Rice OV, Grande AV, Dehktyar N, Bruneus M, Robinson JK, Gatley SJ.

Radiat Environ Biophys. 2009 Apr;48(2):215-25. doi: 10.1007/s00411-009-0220-5. Epub 2009 Mar 4.

PMID:
19259693
10.

Biodistribution of radiolabeled ethanol in rodents.

Gifford AN, Espaillat MP, Gatley SJ.

Drug Metab Dispos. 2008 Sep;36(9):1853-8. doi: 10.1124/dmd.107.020271. Epub 2008 Jun 19.

11.

Applications of Clinical Dopamine Imaging.

Lindsey KP, Gatley SJ.

PET Clin. 2007 Jan;2(1):45-65. doi: 10.1016/j.cpet.2007.09.005. Epub 2007 Nov 22. Review.

PMID:
27157706
12.

Applications of clinical dopamine imaging.

Lindsey KP, Gatley SJ.

Neuroimaging Clin N Am. 2006 Nov;16(4):553-73, vii-viii. Review.

PMID:
17148019
13.

MicroPET investigation of chronic long-term neurotoxicity from heavy ion irradiation.

Rice O, Saintvictor S, Michaelides M, Thanos P, Gatley SJ.

AAPS J. 2006 Aug 4;8(3):E508-14. Review.

14.

Evaluation of the in vivo receptor occupancy for the behavioral effects of cannabinoids using a radiolabeled cannabinoid receptor agonist, R-[125/131I]AM2233.

Dhawan J, Deng H, Gatley SJ, Makriyannis A, Akinfeleye T, Bruneus M, Dimaio AA, Gifford AN.

Synapse. 2006 Aug;60(2):93-101.

PMID:
16715483
15.

Imaging of the brain cannabinoid system.

Lindsey KP, Glaser ST, Gatley SJ.

Handb Exp Pharmacol. 2005;(168):425-43. Review.

PMID:
16596783
16.

Ex vivo imaging of fatty acid amide hydrolase activity and its inhibition in the mouse brain.

Glaser ST, Gatley SJ, Gifford AN.

J Pharmacol Exp Ther. 2006 Mar;316(3):1088-97. Epub 2005 Nov 8.

17.

PET imaging in clinical drug abuse research.

Gatley SJ, Volkow ND, Wang GJ, Fowler JS, Logan J, Ding YS, Gerasimov M.

Curr Pharm Des. 2005;11(25):3203-19. Review.

PMID:
16250850
18.

Potent cannabinergic indole analogues as radioiodinatable brain imaging agents for the CB1 cannabinoid receptor.

Deng H, Gifford AN, Zvonok AM, Cui G, Li X, Fan P, Deschamps JR, Flippen-Anderson JL, Gatley SJ, Makriyannis A.

J Med Chem. 2005 Oct 6;48(20):6386-92.

PMID:
16190764
19.

Low doses of alcohol substantially decrease glucose metabolism in the human brain.

Volkow ND, Wang GJ, Franceschi D, Fowler JS, Thanos PP, Maynard L, Gatley SJ, Wong C, Veech RL, Kunos G, Kai Li T.

Neuroimage. 2006 Jan 1;29(1):295-301. Epub 2005 Aug 8.

PMID:
16085426
20.

Candidate PET radioligands for cannabinoid CB1 receptors: [18F]AM5144 and related pyrazole compounds.

Li Z, Gifford A, Liu Q, Thotapally R, Ding YS, Makriyannis A, Gatley SJ.

Nucl Med Biol. 2005 May;32(4):361-6.

PMID:
15878505
21.

Brain kinetics of methylphenidate (Ritalin) enantiomers after oral administration.

Ding YS, Gatley SJ, Thanos PK, Shea C, Garza V, Xu Y, Carter P, King P, Warner D, Taintor NB, Park DJ, Pyatt B, Fowler JS, Volkow ND.

Synapse. 2004 Sep 1;53(3):168-75.

PMID:
15236349
22.

Evidence that methylphenidate enhances the saliency of a mathematical task by increasing dopamine in the human brain.

Volkow ND, Wang GJ, Fowler JS, Telang F, Maynard L, Logan J, Gatley SJ, Pappas N, Wong C, Vaska P, Zhu W, Swanson JM.

Am J Psychiatry. 2004 Jul;161(7):1173-80.

PMID:
15229048
23.

DRD2 gene transfer into the nucleus accumbens core of the alcohol preferring and nonpreferring rats attenuates alcohol drinking.

Thanos PK, Taintor NB, Rivera SN, Umegaki H, Ikari H, Roth G, Ingram DK, Hitzemann R, Fowler JS, Gatley SJ, Wang GJ, Volkow ND.

Alcohol Clin Exp Res. 2004 May;28(5):720-8.

PMID:
15166646
24.

Neuroimaging in drug abuse.

Lindsey KP, Gatley SJ, Volkow ND.

Curr Psychiatry Rep. 2003 Oct;5(5):355-61. Review.

PMID:
13678555
25.

Low monoamine oxidase B in peripheral organs in smokers.

Fowler JS, Logan J, Wang GJ, Volkow ND, Telang F, Zhu W, Franceschi D, Pappas N, Ferrieri R, Shea C, Garza V, Xu Y, Schlyer D, Gatley SJ, Ding YS, Alexoff D, Warner D, Netusil N, Carter P, Jayne M, King P, Vaska P.

Proc Natl Acad Sci U S A. 2003 Sep 30;100(20):11600-5. Epub 2003 Sep 12.

26.

Labeled glucose analogs in the genomic era.

Gatley SJ.

J Nucl Med. 2003 Jul;44(7):1082-6. Review. No abstract available.

27.

Monoamine oxidase A imaging in peripheral organs in healthy human subjects.

Fowler JS, Logan J, Wang GJ, Franceschi D, Volkow ND, Telang F, Pappas N, Ferrieri R, Shea C, Garza V, Xu Y, King P, Schlyer D, Gatley SJ, Ding YS, Warner D, Netusil N, Carter P, Jayne M, Alexoff D, Zhu W, Vaska P.

Synapse. 2003 Sep 1;49(3):178-87.

PMID:
12774302
28.

Mechanism of action of methylphenidate: insights from PET imaging studies.

Volkow ND, Fowler JS, Wang G, Ding Y, Gatley SJ.

J Atten Disord. 2002;6 Suppl 1:S31-43.

PMID:
12685517
29.

Brain dopamine is associated with eating behaviors in humans.

Volkow ND, Wang GJ, Maynard L, Jayne M, Fowler JS, Zhu W, Logan J, Gatley SJ, Ding YS, Wong C, Pappas N.

Int J Eat Disord. 2003 Mar;33(2):136-42.

PMID:
12616579
30.

Cardiovascular effects of methylphenidate in humans are associated with increases of dopamine in brain and of epinephrine in plasma.

Volkow ND, Wang GJ, Fowler JS, Molina PE, Logan J, Gatley SJ, Gifford A, Ding YS, Wong C, Pappas NR, Zhu W, Swanson JM.

Psychopharmacology (Berl). 2003 Mar;166(3):264-70. Epub 2003 Feb 13.

PMID:
12589522
31.

In vivo imaging of the brain cannabinoid receptor.

Gifford AN, Makriyannis A, Volkow ND, Gatley SJ.

Chem Phys Lipids. 2002 Dec 31;121(1-2):65-72. Review.

PMID:
12505691
32.

Effects of alcohol detoxification on dopamine D2 receptors in alcoholics: a preliminary study.

Volkow ND, Wang GJ, Maynard L, Fowler JS, Jayne B, Telang F, Logan J, Ding YS, Gatley SJ, Hitzemann R, Wong C, Pappas N.

Psychiatry Res. 2002 Dec 30;116(3):163-72.

PMID:
12477600
33.

Role of dopamine in the therapeutic and reinforcing effects of methylphenidate in humans: results from imaging studies.

Volkow ND, Fowler JS, Wang GJ, Ding YS, Gatley SJ.

Eur Neuropsychopharmacol. 2002 Dec;12(6):557-66. Review.

PMID:
12468018
34.

PET imaging of monoamine oxidase B in peripheral organs in humans.

Fowler JS, Logan J, Wang GJ, Volkow ND, Zhu W, Franceschi D, Pappas N, Ferrieri R, Shea C, Garza V, Xu Y, MacGregor RR, Schlyer D, Gatley SJ, Ding YS, Alexoff D.

J Nucl Med. 2002 Oct;43(10):1331-8.

35.

Study of brain uptake and biodistribution of [11C]toluene in non-human primates and mice.

Gerasimov MR, Ferrieri RA, Schiffer WK, Logan J, Gatley SJ, Gifford AN, Alexoff DA, Marsteller DA, Shea C, Garza V, Carter P, King P, Ashby CR Jr, Vitkun S, Dewey SL.

Life Sci. 2002 Apr 26;70(23):2811-28.

PMID:
12269385
36.

Brain DA D2 receptors predict reinforcing effects of stimulants in humans: replication study.

Volkow ND, Wang GJ, Fowler JS, Thanos PP, Logan J, Gatley SJ, Gifford A, Ding YS, Wong C, Pappas N.

Synapse. 2002 Nov;46(2):79-82. Erratum in: Synapse. 2003 Mar 15;47(4):295.. Thanos Pether [corrected to Thanos Panayotis Peter K].

PMID:
12211085
37.

"Nonhedonic" food motivation in humans involves dopamine in the dorsal striatum and methylphenidate amplifies this effect.

Volkow ND, Wang GJ, Fowler JS, Logan J, Jayne M, Franceschi D, Wong C, Gatley SJ, Gifford AN, Ding YS, Pappas N.

Synapse. 2002 Jun 1;44(3):175-80.

PMID:
11954049
38.

Relationship between blockade of dopamine transporters by oral methylphenidate and the increases in extracellular dopamine: therapeutic implications.

Volkow ND, Wang GJ, Fowler JS, Logan J, Franceschi D, Maynard L, Ding YS, Gatley SJ, Gifford A, Zhu W, Swanson JM.

Synapse. 2002 Mar 1;43(3):181-7.

PMID:
11793423
39.

Imaging the neurochemistry of nicotine actions: studies with positron emission tomography.

Volkow ND, Fowler JS, Ding YS, Wang GJ, Gatley SJ.

Nicotine Tob Res. 1999;1 Suppl 2:S127-32; discussion S139-40. Review.

PMID:
11768169
40.

Non-MAO A binding of clorgyline in white matter in human brain.

Fowler JS, Logan J, Ding YS, Franceschi D, Wang GJ, Volkow ND, Pappas N, Schlyer D, Gatley SJ, Alexoff D, Felder C, Biegon A, Zhu W.

J Neurochem. 2001 Dec;79(5):1039-46.

41.

Loss of dopamine transporters in methamphetamine abusers recovers with protracted abstinence.

Volkow ND, Chang L, Wang GJ, Fowler JS, Franceschi D, Sedler M, Gatley SJ, Miller E, Hitzemann R, Ding YS, Logan J.

J Neurosci. 2001 Dec 1;21(23):9414-8.

42.

Effects of endogenous neurotransmitters on the in vivo binding of dopamine and 5-HT radiotracers in mice.

Rice OV, Gatley SJ, Shen J, Huemmer CL, Rogoz R, DeJesus OT, Volkow ND, Gifford AN.

Neuropsychopharmacology. 2001 Nov;25(5):679-89.

43.

Species differences in [11C]clorgyline binding in brain.

Fowler JS, Ding YS, Logan J, MacGregor RR, Shea C, Garza V, Gimi R, Volkow ND, Wang GJ, Schlyer D, Ferrieri R, Gatley SJ, Alexoff D, Carter P, King P, Pappas N, Arnett CD.

Nucl Med Biol. 2001 Oct;28(7):779-85.

PMID:
11578898
44.

[(11)]Cocaine: PET studies of cocaine pharmacokinetics, dopamine transporter availability and dopamine transporter occupancy.

Fowler JS, Volkow ND, Wang GJ, Gatley SJ, Logan J.

Nucl Med Biol. 2001 Jul;28(5):561-72. Review.

PMID:
11516700
45.
46.
47.

Higher cortical and lower subcortical metabolism in detoxified methamphetamine abusers.

Volkow ND, Chang L, Wang GJ, Fowler JS, Franceschi D, Sedler MJ, Gatley SJ, Hitzemann R, Ding YS, Wong C, Logan J.

Am J Psychiatry. 2001 Mar;158(3):383-9.

PMID:
11229978
48.

Association of dopamine transporter reduction with psychomotor impairment in methamphetamine abusers.

Volkow ND, Chang L, Wang GJ, Fowler JS, Leonido-Yee M, Franceschi D, Sedler MJ, Gatley SJ, Hitzemann R, Ding YS, Logan J, Wong C, Miller EN.

Am J Psychiatry. 2001 Mar;158(3):377-82.

PMID:
11229977
49.

Therapeutic doses of oral methylphenidate significantly increase extracellular dopamine in the human brain.

Volkow ND, Wang G, Fowler JS, Logan J, Gerasimov M, Maynard L, Ding Y, Gatley SJ, Gifford A, Franceschi D.

J Neurosci. 2001 Jan 15;21(2):RC121.

50.

Effect of amphetamine-induced dopamine release on radiotracer binding to D1 and D2 receptors in rat brain striatal slices.

Gifford AN, Park MH, Kash TL, Herman LM, Park EH, Gatley SJ, Volkow ND.

Naunyn Schmiedebergs Arch Pharmacol. 2000 Nov;362(4-5):413-8.

PMID:
11111836

Supplemental Content

Loading ...
Support Center